Gene Promoter Advances Could Enhance Treatment of Neurological Disorders
A recently developed system for switching on the activity of genes could improve treatments for a broad range of neurological diseases. Esteban Engel, a researcher in viral neuroengineering in the Princeton Neuroscience Institute, and his team have developed new gene promoters – which act like switches to turn on gene expression – that promise to broaden the ability to deliver large genes and keep them active for long periods of time.